Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors

Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors

Abstract Background It is controversial whether patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) should undergo salvage surgery following the combination therapy of tyrosine kinase inhibitors (TKIs) and programmed cell death protein 1 (PD-1) inhibitors. This study...

Full description

Bibliographic Details
Main Authors: Tianyu Jiao, Haowen Tang, Wenwen Zhang, Bingyang Hu, Tao Wan, Yinbiao Cao, Ze Zhang, Yafei Wang, Junning Cao, Mengqiu Cui, Shichun Lu
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Surgery
Subjects:
Hepatocellular carcinoma
Portal vein tumor thrombus
Salvage surgery
Programmed cell death protein 1 inhibitors
Tyrosine kinase inhibitors
Online Access:https://doi.org/10.1186/s12893-023-02291-1

Internet

https://doi.org/10.1186/s12893-023-02291-1

Similar Items